Page last updated: 2024-08-21

alpha-aminopyridine and Synovitis, Pigmented Villonodular

alpha-aminopyridine has been researched along with Synovitis, Pigmented Villonodular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Beckett, B; Hansford, B; Helming, A1
Tap, W1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Synovitis, Pigmented Villonodular

ArticleYear
Tenosynovial giant cell tumor-diffuse type, treated with a novel colony-stimulating factor inhibitor, pexidartinib: initial experience with MRI findings in three patients.
    Skeletal radiology, 2022, Volume: 51, Issue:5

    Topics: Adult; Aminopyridines; Colony-Stimulating Factors; Giant Cell Tumor of Tendon Sheath; Humans; Magnetic Resonance Imaging; Pyrroles; Synovitis, Pigmented Villonodular

2022
ENLIVEN study: Pexidartinib for tenosynovial giant cell tumor (TGCT).
    Future oncology (London, England), 2020, Volume: 16, Issue:25

    Topics: Aminopyridines; Giant Cell Tumor of Tendon Sheath; Humans; Protein Kinase Inhibitors; Pyrroles; Synovitis, Pigmented Villonodular

2020